Novartis Not Tempted To Join COVID-19 Vaccines Race
No Longer Has Capabilities After GSK Asset Swap
Executive Summary
While the traditional players such as Pfizer and GSK, as well as newcomer AstraZeneca, are hot in pursuit of a COVID-19 vaccine, the Swiss major is sticking to drugs, the area where "we do have deep expertise," CEO Vas Narasimhan told journalists.